- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book provides practical guidance on managing renal patients at the end of life stage. It is presented in easily accessible, bullet point style, and is illustrated with case histories from real life patients, and drug tables.
Andere Kunden interessierten sich auch für
- Anita SaxenaHandbook of Nutrition in Kidney Disease76,99 €
- Lasselle PressKidney Disease Cookbook Collection: The Best Kidney-Friendly Recipes From The Essential Kidney Disease Cookbook & The Kidney Diet Cookbook For Two28,99 €
- Dk GuyerKidney Stones Explained14,99 €
- Kidney Diseases in the Developing World and Ethnic Minorities90,99 €
- Kesorn Pechrach WeaverBorn from Kidney Transplant Mother70,99 €
- Kidney Protection164,99 €
- Fahad AzizKidney Failure to Kidney Transplantation29,99 €
-
-
-
This book provides practical guidance on managing renal patients at the end of life stage. It is presented in easily accessible, bullet point style, and is illustrated with case histories from real life patients, and drug tables.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Hurst & Co.
- 2nd edition
- Seitenzahl: 400
- Erscheinungstermin: 5. Juli 2012
- Englisch
- Abmessung: 178mm x 99mm x 15mm
- Gewicht: 227g
- ISBN-13: 9780199695690
- ISBN-10: 0199695695
- Artikelnr.: 34926242
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Hurst & Co.
- 2nd edition
- Seitenzahl: 400
- Erscheinungstermin: 5. Juli 2012
- Englisch
- Abmessung: 178mm x 99mm x 15mm
- Gewicht: 227g
- ISBN-13: 9780199695690
- ISBN-10: 0199695695
- Artikelnr.: 34926242
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Edwina Brown is a clinical nephrologist with a special interest in patient outcomes, particularly the elderly, on dialysis. Over the last decade she has developed an increasing interest in the support and management of renal patients at their end of life. She was an editor of Supportive Care for the Renal Patient, first published by Oxford University Press in 2004 and with a second edition in 2010, has published and lectured extensively on the topic and runs an annual course on Supportive Care for the Renal Patient. She is currently a member of the UK End of Life Care for Advanced Kidney Care Disease Project Board. Fliss qualified in medicine in the UK in 1986. She initially trained in General Practice, and worked as a General Practitioner from 1992 - 2000, then undertook specialist training in palliative medicine between 2000 and 2004. She went on to undertake a PhD at King's College London, on 'Improving the quality of care of patients with Stage 5 Chronic Kidney Disease managed without dialysis' in the Department of Palliative Care, Policy & Rehabilitation at King's College London. She has now gained a HEFCE Clinical Senior Lecturership - one of the first nationally in Palliative Care. She is based at King's College London and King's College Hospital. She has published on the palliative and end of life care needs of renal patients, including on symptoms, withdrawal from dialysis, survival, and use of opioids. Fliss has a keen interest in longitudinal study, including methodological development, and symptom and functional trajectories in the last year of life (including for renal patients).
1: End-stage kidney disease
2: Comorbidity
3: Complications of end-stage kidney disease
4: Causes of death in end-stage kidney disease
5: Health-related quality of life in end-stage kidney disease
6: Symptom assessment and trajectories
7: The management of pain
8: Non-pain symptoms in end-stage kidney disease
9: How to deliver best supportive and palliative care
10: Recognizing dying
11: Communicating with patients and families
12: Ethical and legal considerations
13: Management of the last few days
14: Spiritual and religious care
15: Caring for the carers
16: Wendy Lawson : Drug doses in advanced chronic kidney disease
17: Audit and research in renal end of life care
2: Comorbidity
3: Complications of end-stage kidney disease
4: Causes of death in end-stage kidney disease
5: Health-related quality of life in end-stage kidney disease
6: Symptom assessment and trajectories
7: The management of pain
8: Non-pain symptoms in end-stage kidney disease
9: How to deliver best supportive and palliative care
10: Recognizing dying
11: Communicating with patients and families
12: Ethical and legal considerations
13: Management of the last few days
14: Spiritual and religious care
15: Caring for the carers
16: Wendy Lawson : Drug doses in advanced chronic kidney disease
17: Audit and research in renal end of life care
1: End-stage kidney disease
2: Comorbidity
3: Complications of end-stage kidney disease
4: Causes of death in end-stage kidney disease
5: Health-related quality of life in end-stage kidney disease
6: Symptom assessment and trajectories
7: The management of pain
8: Non-pain symptoms in end-stage kidney disease
9: How to deliver best supportive and palliative care
10: Recognizing dying
11: Communicating with patients and families
12: Ethical and legal considerations
13: Management of the last few days
14: Spiritual and religious care
15: Caring for the carers
16: Wendy Lawson : Drug doses in advanced chronic kidney disease
17: Audit and research in renal end of life care
2: Comorbidity
3: Complications of end-stage kidney disease
4: Causes of death in end-stage kidney disease
5: Health-related quality of life in end-stage kidney disease
6: Symptom assessment and trajectories
7: The management of pain
8: Non-pain symptoms in end-stage kidney disease
9: How to deliver best supportive and palliative care
10: Recognizing dying
11: Communicating with patients and families
12: Ethical and legal considerations
13: Management of the last few days
14: Spiritual and religious care
15: Caring for the carers
16: Wendy Lawson : Drug doses in advanced chronic kidney disease
17: Audit and research in renal end of life care